Harrow, Inc. (HROW)
30.12
+1.82
(+6.43%)
USD |
NASDAQ |
Nov 13, 16:00
30.00
-0.12
(-0.40%)
Pre-Market: 08:44
Harrow Enterprise Value : 1.355B for Nov. 13, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2026 | 1.355B |
| November 12, 2026 | 1.287B |
| November 11, 2026 | 1.327B |
| November 10, 2026 | 1.364B |
| November 09, 2026 | 1.256B |
| November 06, 2026 | 1.234B |
| November 05, 2026 | 1.202B |
| November 04, 2026 | 1.304B |
| November 03, 2026 | 1.296B |
| November 02, 2026 | 1.283B |
| October 30, 2026 | 1.285B |
| October 29, 2026 | 1.350B |
| October 28, 2026 | 1.328B |
| October 27, 2026 | 1.316B |
| October 26, 2026 | 1.311B |
| October 23, 2026 | 1.292B |
| October 22, 2026 | 1.281B |
| October 21, 2026 | 1.285B |
| October 20, 2026 | 1.278B |
| October 19, 2026 | 1.264B |
| October 16, 2026 | 1.249B |
| October 15, 2026 | 1.304B |
| October 14, 2026 | 1.247B |
| October 13, 2026 | 1.285B |
| October 12, 2026 | 1.317B |
| Date | Value |
|---|---|
| October 09, 2026 | 1.327B |
| October 08, 2026 | 1.370B |
| October 07, 2026 | 1.374B |
| October 06, 2026 | 1.364B |
| October 05, 2026 | 1.373B |
| October 02, 2026 | 1.369B |
| October 01, 2026 | 1.374B |
| September 30, 2026 | 1.381B |
| September 29, 2026 | 1.394B |
| September 28, 2026 | 1.401B |
| September 25, 2026 | 1.456B |
| September 24, 2026 | 1.457B |
| September 23, 2026 | 1.476B |
| September 22, 2026 | 1.508B |
| September 21, 2026 | 1.488B |
| September 18, 2026 | 1.456B |
| September 17, 2026 | 1.458B |
| September 16, 2026 | 1.499B |
| September 15, 2026 | 1.485B |
| September 14, 2026 | 1.494B |
| September 11, 2026 | 1.509B |
| September 10, 2026 | 1.588B |
| September 09, 2026 | 1.624B |
| September 08, 2026 | 1.635B |
| September 04, 2026 | 1.661B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Viatris, Inc. | 35.55B |
| ANI Pharmaceuticals, Inc. | 1.807B |
| Corcept Therapeutics, Inc. | 7.615B |
| Veru, Inc. | 12.53M |
| Johnson & Johnson | 715.26B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 9.757M |
| Revenue (Quarterly) | 99.30M |
| Total Expenses (Quarterly) | 89.54M |
| EPS Diluted (Quarterly) | 0.2532 |
| Gross Profit Margin (Quarterly) | 75.43% |
| Profit Margin (Quarterly) | 9.83% |
| Earnings Yield | -2.57% |
| Operating Earnings Yield | 0.21% |
| Normalized Earnings Yield | -2.339 |